- Home
- PTGX vs KFY Comparison
PTGX vs KFY Comparison
Compare PTGX & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | KFY |
|---|---|---|
| Founded | 2006 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.4B |
| IPO Year | 2016 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PTGX | KFY |
|---|---|---|
| Price | $89.29 | $66.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $86.44 | $78.00 |
| AVG Volume (30 Days) | ★ 898.7K | 356.2K |
| Earning Date | 11-06-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.91% |
| EPS Growth | N/A | ★ 33.45 |
| EPS | 0.72 | ★ 4.69 |
| Revenue | $209,217,000.00 | ★ $2,763,755,000.00 |
| Revenue This Year | N/A | $4.54 |
| Revenue Next Year | $296.47 | $4.41 |
| P/E Ratio | $124.48 | ★ $14.10 |
| Revenue Growth | N/A | ★ 0.93 |
| 52 Week Low | $33.70 | $59.23 |
| 52 Week High | $93.25 | $78.50 |
Technical Indicators
Market Signals| Indicator | PTGX | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 50.74 |
| Support Level | $83.52 | $65.17 |
| Resistance Level | $90.85 | $67.25 |
| Average True Range (ATR) | 2.63 | 1.34 |
| MACD | -0.33 | 0.40 |
| Stochastic Oscillator | 83.62 | 75.51 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.